神经栓塞设备市场 - 全球市场规模（依细分）、占有率、监管、偿付、程序、预测（～2036年）

本报告对全球神经栓塞设备市场进行了深入分析，包括各地区的市场规模、主要趋势、创新产品和技术以及竞争格局。

市场模型的主要组成如下：

已上市的神经栓塞设备和不断变化的竞争格局

• 主要产业趋势分析
• 神经栓塞设备市场各部分的年收入及市场预测（2015-2036年）
• 单位数量、平均销售价格和市场价值的市场层面资料

全球、区域和国家层面的市场洞察

• 依地区和全球趋势细分的定性市场讯息，并提供每个国家/地区的市场洞察
• 神经栓塞设备市场的SWOT 分析
• 神经栓塞设备市场竞争动态考察与趋势

掌握包括医疗保健系统概况在内的真实全局，加深对市场的了解。此外，市场进入部分提供有关偿付政策和监管环境的资讯，可以更深入地了解市场动态。

• 各国医疗保健体系概述
• 各国的偿付政策
• 各国医疗科技监理状况

目标公司

• Medtronic Plc
• Stryker Corp
• Terumo Neuro
• Cerenovus
• Integra LifeSciences Corp
• Penumbra Inc
• MicroPort Scientific Corp
• Balt SAS
• B. Braun Melsungen AG
• Phenox GmbH
• 其他

Neurovascular Embolization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Procedures and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Neurology Devices therapeutic area.

Neurovascular embolization devices are used to treat abnormalities in blood vessels in the brain, namely, brain aneurysms and arteriovenous malformations (AVM). These devices occlude or prevent blood flow to unwanted vessel malformations. Aneurysm clips, liquid embolic systems, flow diversion stents, embolization coils and intrasaccular flow disruptors are tracked under this segment. Embolization coils are the most preferred method of treatment for brain aneurysms, followed by aneurysm clips and flow diversion stents.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Neurovascular Embolization Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Neurovascular Embolization Devices market revenue by segment and market outlooks from 2015-2036.
• Market level data on units, average selling prices and market values.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition, GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Neurovascular Embolization Devices market.
• Competitive dynamics insights and trends provided for Neurovascular Embolization Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered - Medtronic Plc, Stryker Corp, Terumo Neuro, Cerenovus, Integra LifeSciences Corp, Penumbra Inc, MicroPort Scientific Corp, Balt SAS, B. Braun Melsungen AG, Phenox GmbH and Others

Countries covered - United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Neurovascular Embolization Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Neurovascular Embolization Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Neurovascular Embolization Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Neurovascular Embolization Devices market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.